<HTML lang="en" dir="ltr" class="client-nojs">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Team_Linkoping_Sweden_Science2Go_06_22 skin-igem action-view"><DIV id="globalWrapper"><DIV id="content" class="mw-body" role="main"><H1 id="firstHeading" class="firstHeading"><SPAN dir="auto">Team:Linkoping Sweden/Science2Go/06 22</SPAN></H1><DIV id="bodyContent"><DIV id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><DIV id="html-menu-container"><DIV id="html-menu-right"><DIV id="html-menu"><A href="https://2015.igem.org/Team:Linkoping_Sweden/Description">Project</A><A href="https://2015.igem.org/Team:Linkoping_Sweden/Team">Team</A><A href="https://2015.igem.org/Team:Linkoping_Sweden/Modeling">Modeling</A><A class="menu-selected" href="https://2015.igem.org/Team:Linkoping_Sweden/Practices">Policy and
                    Practice</A><A href="https://2015.igem.org/Team:Linkoping_Sweden/Detector">Detector</A><A href="https://2015.igem.org/Team:Linkoping_Sweden/Notebook">Notebook</A><A href="https://2015.igem.org/Team:Linkoping_Sweden/Results">Result</A><A href="https://2015.igem.org/Team:Linkoping_Sweden/Safety">Safety</A></DIV><DIV id="html-sub-menu"><A href="https://2015.igem.org/Team:Linkoping_Sweden/Practices">Overview</A><A href="https://2015.igem.org/Team:Linkoping_Sweden/Book">Children's Book</A><A href="https://2015.igem.org/Team:Linkoping_Sweden/Market_Survey">Market Survey</A><A href="https://2015.igem.org/Team:Linkoping_Sweden/Knowledge_Survey">Knowledge Survey</A><A href="https://2015.igem.org/Team:Linkoping_Sweden/Interview">Interview</A><A href="https://2015.igem.org/Team:Linkoping_Sweden/Science2Go">Science 2 Go</A><A href="https://2015.igem.org/Team:Linkoping_Sweden/Music_Video">Music Video</A></DIV></DIV></DIV><DIV id="content-container" class="container"><DIV class="row"><H3>New possible therapeutics for food allergy</H3><H5 class="caption">2015-06-22</H5><DIV class="col-xs-6"><P>
                    Food allergy diseases have rapidly increased during the last few decades. There are no therapeutics
                    for people suffering from food allergies. Today’s treatments are only based on treating the symptoms
                    which arise when the patient accidently get in contact with the allergens. Therefore the fears of
                    accidental ingestion significantly impair the quality of life for millions of people around the
                    world. Food allergy is an immune mediated response to specific proteins in food; in most cases the
                    antibody IgE is responsible for triggering the response. One of the most promising new therapeutics
                    for the treatment of food allergy is Omalizumabwhich binds IgE, thereby preventing it to bind FcεRI,
                    the high-affinity IgE receptor expressed on mast cells and basophiles. These two cells are both
                    white blood cells that contain granules of histamine. When Omalizumab binds the antibody it causes
                    the serum IgE levels to dramatically reduce which in turn decreases the FcεRI expression on
                    basophils and mast cells. When the FcεRI receptors lessen, the levels of released histamines
                    decrease and thereby preventing allergic symptoms. Still, Omalizumab is only one of many allergy
                    therapeutics targeting the IgE-interactions that is advancing with positive results showing great
                    prospect for future research.
                </P></DIV><DIV class="col-xs-6"><P class="caption">
                    Find other Science 2 Go articles <A href="https://2015.igem.org/Team:Linkoping_Sweden/Science2Go">here</A>!
                </P><P>
                    More comprehensive trials are needed to determine the safety and
                    efficiency of these therapeutics. Anyhow, continued advancement in understanding these mechanisms
                    gives hope that a treatment for food allergy will be available in the near future.
                </P><H3>Reference</H3><P>
                    Rebecca N. Bauer, Monali Manohar, Anne Marie Singh, David C. Jay, Kari C. Nadeau. ”The future of
                    biologics: Applications for food allergy” Journal of Allergy and Clinical Immunology, February 2015
                </P></DIV></DIV></DIV><DIV id="footer"><DIV class="container"><DIV class="col-xs-3"><B>Linköping University</B><UL class="list-unstyled"><LI><A href="http://www.liu.se/om-liu?l=en" target="_blank">About Linköping University</A></LI><LI><A href="http://www.liu.se/forskning/forskningsomraden?l=en" target="_blank">Research areas</A></LI><LI><A href="http://www.liu.se/utbildning/exchange-students?l=en" target="_blank">Study abroad</A></LI></UL></DIV><DIV class="col-xs-offset-2 col-xs-3"><B>LiU iGEM</B><UL class="list-unstyled"><LI>Linköping University</LI><LI>581 83 Linköping</LI><LI>Sweden</LI></UL></DIV></DIV></DIV></DIV></DIV></DIV></DIV></BODY></HTML>